Gaslightwala Abizer

Track record

How each disclosed position did against the S&P ~6 months later

The outcome curve and every position's resultPro →

-71.2%

median move per position

+14.4%

S&P 500 median, same spans

0 of 1

beat the S&P ~6mo later

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$56.7K bought

All filings on record

Every Form 4 transaction we track for this filer

All10Buys7Sells0

Stock	Transaction	Date	~6mo vs S&P
AKTXAkari Therapeutics Plc	Buy $2.7K · 3,000 sh	2025-08-25	—
AKTXAkari Therapeutics Plc	Buy $7.4K · 8,000 sh	2025-08-22	—
AKTXAkari Therapeutics Plc	Buy $9.4K · 10,000 sh	2025-08-21	—
AKTXAkari Therapeutics Plc	Buy $6.0K · 5,203 sh	2025-06-24	—
AKTXAkari Therapeutics Plc	Buy $1.1K · 943 sh	2025-06-23	—
AKTXAkari Therapeutics Plc	Buy $12.0K · 10,000 sh	2025-06-20	—
AKTXAkari Therapeutics Plc	Buy $18.0K · 15,000 sh	2025-06-17	—
AKTXAkari Therapeutics Plc	Grant $29.8K · 25,000 sh	2025-06-13	—
AKTXAkari Therapeutics Plc	Grant $24.6K · 20,000 sh	2025-06-12	—
AKTXAkari Therapeutics Plc	Grant $25.4K · 20,000 sh	2025-06-10	—

AKTXBuy

2025-08-25 · Akari Therapeutics Plc

$2.7K

—

AKTXBuy

2025-08-22 · Akari Therapeutics Plc

$7.4K

—

AKTXBuy

2025-08-21 · Akari Therapeutics Plc

$9.4K

—

AKTXBuy

2025-06-24 · Akari Therapeutics Plc

$6.0K

—

AKTXBuy

2025-06-23 · Akari Therapeutics Plc

$1.1K

—

AKTXBuy

2025-06-20 · Akari Therapeutics Plc

$12.0K

—

AKTXBuy

2025-06-17 · Akari Therapeutics Plc

$18.0K

—

AKTXGrant

2025-06-13 · Akari Therapeutics Plc

$29.8K

—

AKTXGrant

2025-06-12 · Akari Therapeutics Plc

$24.6K

—

AKTXGrant

2025-06-10 · Akari Therapeutics Plc

$25.4K

—

10 filings·Every Form 4 on record, with outcomesPro →

Filing in the same companies

Other insiders active in these names in the last 3 years

FK

Farag Kameel D.

AKTX · last 2026-08-17

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.